Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVALUNG ETOILE: Lung Cancer Screening Program
NCT05649046Active, not recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Number of complete phenotyping clinical at 18 months, Number of complete phenotyping radiological at 18 months and 1 more. Started Jan 2023; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05649046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649046.